ABBV CIK: 1551152

AbbVie Inc.

  • United States
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
27.9
FY22:
28.5
FY23:
33.0
FY24:
25.6
FY25:
29.1
(positive)
Change from FY21 to FY25
billions USD
FY21:
119
FY22:
110
FY23:
102
FY24:
110
FY25:
105
Total assets
Change from FY21 to FY25
billions USD
FY21:
147
FY22:
139
FY23:
135
FY24:
135
FY25:
134

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
35.2
FY22:
29.5
FY23:
37.8
FY24:
38.7
FY25:
43.3
(negative)
Change from FY21 to FY25
billions USD
FY21:
95.9
FY22:
92.0
FY23:
86.5
FY24:
93.0
FY25:
93.9
(positive)
Change from FY21 to FY25
billions USD
FY21:
15.4
FY22:
17.3
FY23:
10.4
FY24:
3.33
FY25:
−3.27
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
147
FY22:
139
FY23:
135
FY24:
135
FY25:
134

All amounts in billions USD Data sources:SEC EDGARTwelve Data